Iron Carbohydrate Complexes: Characteristics and Regulatory Challenges
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-319-16241-6_5
Reference67 articles.
1. Aguera ML, Martin-Malo A, Álvares de Lara MA et al (2014) The treatment with generic iv iron needs a higher dose of iron and ESA to keep hemoglobin stable. Nefrologia 34(S1):abstr 319
2. Andrews NC (2008) Forging a field: the golden age of iron biology. Blood 112:219–230
3. Auerbach M, Ballard H (2010) Clinical use of intravenous iron: administration, efficacy, and safety. Hematology Am Soc Hematol Educ Program 2010:338–347
4. Bailie GR (2012) Comparison of rates of reported adverse events associated with IV iron products in the United States. Am J Health Syst Pharm 69(4):310–320
5. Bailie GR, Schuler C, Leggett RE, Levin R (2013a) Oxidative effect ferumoxytol and iron dextran on urinary bladder contraction and impact of antioxidants. Free Radic Antioxid 3(1):7–10
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. An Analytical Method for Determination of Total Iron in Pharmaceuticalgrade Intravenous Iron Colloidal Complexes by Redox-Potentiometry;Pharmaceutical Nanotechnology;2023-10
2. A comprehensive study of intravenous iron-carbohydrate nanomedicines: From synthesis methodology to physicochemical and pharmaceutical characterization;Journal of Carbohydrate Chemistry;2023-03-24
3. Non-biological Complex Drugs (NBCDs): Complex Pharmaceuticals in Need of Individual Robust Clinical Assessment Before Any Therapeutic Equivalence Decision;Frontiers in Medicine;2020-11-23
4. Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: From production to clinical practice;Nanomedicine: Nanotechnology, Biology and Medicine;2020-06
5. Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: “Drug Products, Including Biological Products, that Contain Nanomaterials”;The AAPS Journal;2019-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3